Golden
ORI Capital

ORI Capital

A Hong Kong based venture capital firm investing in healthcare technology

ORI Capital is venture capital firm headquartered in Hong Kong. It was founded in 2015 by Simone Song, who was the Managing Director of China Healthcare at Goldman Sachs from 2010-2015. The management team of the firm is comprised of former Goldman Sachs executives and healthcare scientists. In 2017, the fund was valued at $200 million.



ORI Capital targets investment in the global healthcare technology industry. In 2016, ORI Capital invested $100 million in Kymab, a biopharmeutical company developing human anti-body based therapies.





Timeline

Funded Companies

1 Result
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Cold Genesys is a privately-held, immunotherapy based biopharmaceutical company

Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References